Research News and Research

RSS

$90 million approved for first-of-its-kind translational research building for mental health

Yesterday, during a meeting of the Executive Appropriations Committee of the Utah State Legislature, lawmakers unanimously approved $90 million in funding for the Utah Translational Research Building at the University of Utah Huntsman Mental Health Institute.

18 Sep 2021

Thousands of vulnerable hospital patients set to benefit from new COVID-19 treatment

Thousands of vulnerable NHS patients in hospital due to COVID-19 are set to benefit from a ground-breaking new antibody treatment, the government has announced today (17 September 2021).

18 Sep 2021

Health Secretary gives blood sample for new genomic sequencing program

Health and Social Care Secretary Sajid Javid visited Great Ormond Street Hospital today to provide a blood sample for a genomic sequencing programme aimed at tackling disparities in health.

18 Sep 2021

Researchers use high-tech 3D facial scans to better understand the genetic causes of autism

New Australian research is using high-tech 3D facial scans to give us a better understanding of the genetic causes of autism.

17 Sep 2021

Scientists identify new approach to overcome resistance to cancer immunotherapy

Hokkaido University scientists and colleagues in Japan have found a way that could help some patients overcome resistance to immunotherapy treatment for cancer. The approach, proven in mice experiments, was reported in the Journal for Immunotherapy of Cancer.

17 Sep 2021

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

A study evaluates the efficacy of a mAb to prevent disease progression in non-hospitalized persons with symptomatic SARS-CoV-2 infection.

17 Sep 2021

Study finds risk factors for early COPD among Hispanics and Latinos in the U.S.

Chronic obstructive pulmonary disease (COPD) is a progressive disorder that is often not diagnosed until a patient is over 60 years old and has substantial airflow obstruction. At this stage, it can be difficult to manage and treat the condition. To identify those at risk and intervene earlier, several studies have examined risk factors for COPD.

17 Sep 2021

Researchers report six stages of engagement in treatment of ADHD

Six stages of engagement in treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) have been reported by researchers at Boston Medical Center based on a diverse study, inclusive of parents of predominantly racial and ethnic minority children with ADHD.

17 Sep 2021

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

A team of international scientists and clinical experts have unraveled a new cell type in human skin that contributes to inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis (PSO). Their study findings were published in the Journal of Experimental Medicine in September 2021.

17 Sep 2021

Review: Long COVID symptoms rarely persisted beyond 12 weeks in young people

Long COVID symptoms rarely persisted beyond 12 weeks in children and adolescents, unlike adults. But more studies were required to investigate the risk and impact of long COVID in young people to help guide vaccine policy decisions in Australia, according to a review led by the Murdoch Children's Research Institute (MCRI).

17 Sep 2021

Scientists examine kids’ unique immune systems as more fall victim to covid

Eighteen months into the covid-19 pandemic, with the delta variant fueling a massive resurgence of disease, many hospitals are hitting a heartbreaking new low. They're now losing babies to the coronavirus.

17 Sep 2021

Dentists chip away at uninsured problem by offering patients membership plans

Nevada dentist David White has seen diseased and rotted teeth in the mouths of patients who routinely put off checkups and avoided minor procedures such as fillings. While dental phobia is a factor, White said, the overriding reason people avoid treatment is cost.

17 Sep 2021

Covid-overwhelmed hospitals postpone cancer care and other treatment

It's a bad time to get sick in Oregon. That's the message from some doctors, as hospitals fill up with covid-19 patients and other medical conditions go untreated.

17 Sep 2021

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

GammaDelta Therapeutics Ltd., a biotechnology company pioneering the discovery and development of allogeneic gamma delta T cell therapies for cancer, today announced that it has initiated a first-in-human Phase I clinical trial evaluating GDX012 for the treatment of acute myeloid leukemia.

17 Sep 2021

Researchers take major step forward in the development of microbial fuel cells

A UCLA-led team of engineers and chemists has taken a major step forward in the development of microbial fuel cells - a technology that utilizes natural bacteria to extract electrons from organic matter in wastewater to generate electrical currents.

17 Sep 2021

OSU-led collaboration proposes broadening of university promotion, tenure criteria and innovation

University promotion and tenure criteria and processes should be broadened and made more inclusive to value innovation, entrepreneurship and other forms of scholarly impact, a collaboration led by Oregon State University assert today in a paper published in Science.

17 Sep 2021

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines.

17 Sep 2021

Research News and Research

$90 million approved for first-of-its-kind translational research building for mental health

Thousands of vulnerable hospital patients set to benefit from new COVID-19 treatment

Health Secretary gives blood sample for new genomic sequencing program

Researchers use high-tech 3D facial scans to better understand the genetic causes of autism

Scientists identify new approach to overcome resistance to cancer immunotherapy

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

Study finds risk factors for early COPD among Hispanics and Latinos in the U.S.

Researchers report six stages of engagement in treatment of ADHD

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

Review: Long COVID symptoms rarely persisted beyond 12 weeks in young people

Scientists examine kids’ unique immune systems as more fall victim to covid

Dentists chip away at uninsured problem by offering patients membership plans

Covid-overwhelmed hospitals postpone cancer care and other treatment

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

Researchers take major step forward in the development of microbial fuel cells

OSU-led collaboration proposes broadening of university promotion, tenure criteria and innovation

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV

Research could help design peptides to halt antibiotic-resistant bacteria

Urine sampling not to be restricted to children with unexplained fever, say researchers

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

New horizons in drug discovery: High-throughput & target-to-therapy advances

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology